Authors: DINGEMANSE J WOOD N GUENTERT T OIE S OUWERKERK M AMREIN R

Citation: J. Dingemanse et al., CLINICAL-PHARMACOLOGY OF MOCLOBEMIDE DURING CHRONIC ADMINISTRATION OFHIGH-DOSES TO HEALTHY-SUBJECTS, Psychopharmacology, 140(2), 1998, pp. 164-172

Authors: HOOGKAMER JFW KLEINBLOESEM CH OUWERKERK M HOGEMANN A NOKHODIAN A KIRCH W WEIDEKAMM E

Citation: Jfw. Hoogkamer et al., PHARMACOKINETICS AND SAFETY OF CANDESARTAN CILEXETIL IN SUBJECTS WITHNORMAL AND IMPAIRED LIVER-FUNCTION, European Journal of Clinical Pharmacology, 54(4), 1998, pp. 341-345

Authors: DINGEMANSE J KLEINBLOESEM CH HOOGKAMER JFW OUWERKERK M HOGEMANN A NOKHODIAN A

Citation: J. Dingemanse et al., COMPARATIVE PHARMACOKINETICS OF MULTIPLE-DOSE CANDESARTAN IN SUBJECTSWITH AND WITHOUT IMPAIRED HEPATIC-FUNCTION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 61-61

Authors: VANDERSLUIS P OUWERKERK M DUINE PA

Citation: P. Vandersluis et al., OPTICAL SWITCHES BASED ON MAGNESIUM LANTHANIDE ALLOY HYDRIDES, Applied physics letters, 70(25), 1997, pp. 3356-3358

Authors: WIEGEL M BLASSE G OUWERKERK M

Citation: M. Wiegel et al., BOND-ORBITAL CALCULATIONS OF THE NONLINEAR-OPTICAL RESPONSE OF LITHIUM NIOBATE-RELATED COMPOUNDS, Journal of physics. Condensed matter, 7(3), 1995, pp. 675-682

Authors: KLEINBLOESEM CH OUWERKERK M SPITZNAGEL W WILKINSON FE KAISER RR

Citation: Ch. Kleinbloesem et al., PHARMACOKINETICS AND BIOAVAILABILITY OF PERCUTANEOUS IBUPROFEN, Arzneimittel-Forschung, 45-2(10), 1995, pp. 1117-1121